Nanopore sequencing reveals U2AF1 S34F-associated full-length isoforms
Cameron M. SouletteiD, Eva Hrabeta‐RobinsoniD, Alison D. TangiD, Maximillian G. MariniD, Angela Norie BrooksiD
Abstract
U2AF1 S34F is one of the most recurrent splicing factor mutations in lung adenocarcinoma (ADC) and has been shown to cause transcriptome-wide pre-mRNA splicing alterations. While U2AF1 S34F-associated splicing alterations have been described, the function of altered mRNA isoform changes remains largely unexplored. To better understand the impact U2AF1 S34F has on isoform fate and function, we conducted high-throughput long-read cDNA sequencing from isogenic human bronchial epithelial cells with and without U2AF1 S34F mutation. We found that nearly 75% (49,366) of our long-read constructed multiexon isoforms do not overlap GENCODE or short-read assembled isoforms. We found 198 transcript isoforms with significant expression and usage changes caused by U2AF1 S34F mutation, including a novel lncRNA. Isoforms from immune-related genes were largely downregulated in mutant cells, none of which were found to have splicing changes. Finally, isoforms likely targeted by nonsense-mediated decay were preferentially downregulated in U2AF1 S34F cells, suggesting that the impact of observed isoform changes may alter the translational output of affected genes. Altogether, long-read sequencing provided additional insights into transcriptome alterations and downstream functional consequences associated with U2AF1 S34F mutation.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Wild-type U2AF1 antagonizes the splicing program characteristic of U2AF1-mutant tumors and is required for cell survival
Dennis Liang Fei, Hayley Motowski, … Harold Varmus·bioRxiv·Aug 24, 2016
- The splicing factor U2AF1 contributes to cancer progression through a non-canonical role in translation regulation
M. Palangat, D. Anastsakis, … D. Larson·bioRxiv·Jul 18, 2018
- U2AF1 mutations rescue deleterious exon skipping induced by KRAS mutations
David M. Walter, Katherine Cho, … Matthew M. Meyerson·Nature GeneticsPeer-reviewed·Jul 1, 2026
- Multi-omics profiling of U2AF1 mutants dissects pathogenic mechanisms affecting RNA granules in myeloid malignancies
G. Biancon, P. Joshi, … S. Halene·bioRxiv·Apr 22, 2021
- U2AF1 mutations alter splice site recognition in hematological malignancies
Janine O Ilagan, Aravind Ramakrishnan, … Robert K Bradley·bioRxiv·Sep 29, 2014
- U2AF1 S34F enhances tumorigenic potential of lung cells by exhibiting synergy with KRAS mutation and altering response to environmental stress
Cindy E Liang, Eva Hrabeta‐Robinson, … Angela Norie Brooks·bioRxiv·Sep 11, 2024